Skip to main content

Articles

Page 7 of 70

  1. Accurate surrogate parameters for radio resistance are warranted for individualized radiotherapy (RT) concepts in prostate cancer (PCa). The purpose of this study was to assess intertumoral heterogeneity in te...

    Authors: Ioana M. Marinescu, Manuel Rogg, Simon Spohn, Moritz von Büren, Marius Kamps, Cordula A. Jilg, Elena Fountzila, Kyriaki Papadopoulou, Lara Ceci, Alisa Bettermann, Juri Ruf, Matthias Benndorf, Sonja Adebahr, Daniel Zips, Anca L. Grosu, Christoph Schell…
    Citation: Radiation Oncology 2022 17:163
  2. To assess the impact of systematic setup and range uncertainties for robustly optimized (RO) intensity modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) plans in patients with localiz...

    Authors: Michael P. Butkus, Nellie Brovold, Tejan Diwanji, Yihang Xu, Mariluz De Ornelas, Alan Dal Pra, Matt Abramowitz, Alan Pollack and Nesrin Dogan
    Citation: Radiation Oncology 2022 17:162
  3. The standard therapy for brain metastasis was surgery combined with whole brain radiotherapy (WBRT). The latter is however, associated with important neurocognitive toxicity. To reduce this toxicity, postopera...

    Authors: Marie Cantaloube, Mohamed Boucekine, Anne Balossier, Xavier Muracciole, Mickael Meyer, Christine Delsanti, Romain Carron, Yassine Mohamed Beltaifa, Domnique Figarella-Branger, Jean Regis and Laetitia Padovani
    Citation: Radiation Oncology 2022 17:160
  4. Soft tissue sarcomas (STS) represent a diverse group of rare malignant tumors. Currently, five to six weeks of preoperative radiotherapy (RT) combined with surgery constitute the mainstay of therapy for local...

    Authors: Siyer Roohani, Felix Ehret, Marta Kobus, Anne Flörcken, Sven Märdian, Jana Käthe Striefler, Daniel Rau, Robert Öllinger, Armin Jarosch, Volker Budach and David Kaul
    Citation: Radiation Oncology 2022 17:159
  5. Many patients with incurable esophageal cancer (ECa) present with dysphagia as their predominant symptom. Currently there is no consensus on how best to initially manage this scenario with multiple therapeutic...

    Authors: Swetha Sridharan, Fiona Day, Jasmin Loh, James Lynam, Joanne Smart, Brandan Holt, Hiren Mandaliya, Anthony Bonaventura, Mahesh Kumar and Jarad Martin
    Citation: Radiation Oncology 2022 17:158
  6. Online adaptive stereotactic radiotherapy allows for improved target and organ at risk (OAR) delineation and inter-fraction motion management via daily adaptive planning. The use of adaptive SBRT for the treat...

    Authors: Minsol Kim, Joshua P. Schiff, Alex Price, Eric Laugeman, Pamela P. Samson, Hyun Kim, Shahed N. Badiyan and Lauren E. Henke
    Citation: Radiation Oncology 2022 17:157
  7. Stereotactic body radiotherapy (SBRT) is a promising approach in treating painful bone metastases. However, the superiority of SBRT over conventional external beam radiotherapy (cEBRT) remains controversial. T...

    Authors: Kei Ito, Tetsuo Saito, Naoki Nakamura, Nobuki Imano and Peter Hoskin
    Citation: Radiation Oncology 2022 17:156
  8. To compare the dosimetric profiles of volumetric modulated arc therapy (VMAT) plans using the fast-rotating O-ring linac (the Halcyon system) based on a dual-layer stacked multi-leaf collimator and helical tom...

    Authors: Sang Gyu Ju, Yong Chan Ahn, Yeong-bi Kim, Jin Man Kim, Dong Yeol Kwon, Byoung Suk Park and Kyungmi Yang
    Citation: Radiation Oncology 2022 17:155
  9. The CyberKnife Xsight lung-tracking system (XLTS) provides an alternative to fiducial-based target-tracking systems (FTTS) for non-small-cell lung cancer (NSCLC) patients without invasive fiducial insertion pr...

    Authors: Thomas J. Klein, Suki Gill, Martin A. Ebert, Garry Grogan, Warwick Smith, Zaid Alkhatib, John Geraghty, Alison J. D. Scott, Alan Brown and Pejman Rowshanfarzad
    Citation: Radiation Oncology 2022 17:154
  10. Accompanied by the demographic change, the number of octogenarian cancer patients with bone metastases will increase in the future. Palliative radiotherapy constitutes an effective analgesic treatment; however...

    Authors: Alexander Rühle, Verlaine Ange Nya Yompang, Simon K. B. Spohn, Raluca Stoian, Constantinos Zamboglou, Eleni Gkika, Anca-Ligia Grosu, Nils H. Nicolay and Tanja Sprave
    Citation: Radiation Oncology 2022 17:153
  11. Fast and accurate outlining of the organs at risk (OARs) and high-risk clinical tumor volume (HRCTV) is especially important in high-dose-rate brachytherapy due to the highly time-intensive online treatment pl...

    Authors: Zhen Li, Qingyuan Zhu, Lihua Zhang, Xiaojing Yang, Zhaobin Li and Jie Fu
    Citation: Radiation Oncology 2022 17:152
  12. We developed a novel concept, equivalent uniform length (EUL), to describe the relationship between the generalized equivalent uniform dose (EUD) and the geometric anatomy around a tumor target. By correlating...

    Authors: Cheng Tao, Bo Liu, Chengqiang Li, Jian Zhu, Yong Yin and Jie Lu
    Citation: Radiation Oncology 2022 17:151
  13. To investigate the performance of a narrow-scope knowledge-based RapidPlan (RP) model for optimisation of intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) plans applied to ...

    Authors: Davide Franceschini, Luca Cozzi, Antonella Fogliata, Beatrice Marini, Luciana Di Cristina, Luca Dominici, Ruggero Spoto, Ciro Franzese, Pierina Navarria, Tiziana Comito, Giacomo Reggiori, Stefano Tomatis and Marta Scorsetti
    Citation: Radiation Oncology 2022 17:150
  14. Authors: Sebastian Marschner, Manasi Datar, Aurélie Gaasch, Zhoubing Xu, Sasa Grbic, Guillaume Chabin, Bernhard Geiger, Julian Rosenman, Stefanie Corradini, Maximilian Niyazi, Tobias Heimann, Christian Möhler, Fernando Vega, Claus Belka and Christian Thieke
    Citation: Radiation Oncology 2022 17:149

    The original article was published in Radiation Oncology 2022 17:129

  15. The outcome of patients with T4 esophageal squamous cell carcinoma (ESCC) is extremely poor. Two distinct therapeutic options are currently available for T4 esophageal cancers: neochemoradiotherapy followed by...

    Authors: Tian Zhang, Zhoubo Guo, Xi Chen, Jie Dong, Hongjing Jiang, Peng Tang, Ping Wang, Dong Qian, Wencheng Zhang and Qingsong Pang
    Citation: Radiation Oncology 2022 17:148
  16. This study investigated whether radiomic features can improve the prediction accuracy for tumor recurrence over clinicopathological features and if these features can be used to identify high-risk patients req...

    Authors: Chae Jung Park, Seo Hee Choi, Jihwan Eom, Hwa Kyung Byun, Sung Soo Ahn, Jong Hee Chang, Se Hoon Kim, Seung-Koo Lee, Yae Won Park and Hong In Yoon
    Citation: Radiation Oncology 2022 17:147
  17. Magnetic resonance-guided radiotherapy (MRgRT) utilization is rapidly expanding, driven by advanced capabilities including better soft tissue imaging, continuous intrafraction target visualization, automatic t...

    Authors: Berend J. Slotman, Mary Ann Clark, Enis Özyar, Myungsoo Kim, Jun Itami, Agnès Tallet, Jürgen Debus, Raphael Pfeffer, PierCarlo Gentile, Yukihiro Hama, Nicolaus Andratschke, Olivier Riou, Philip Camilleri, Claus Belka, Magali Quivrin, BoKyong Kim…
    Citation: Radiation Oncology 2022 17:146
  18. This study aims​ to report preclinical validation, and the first clinical treatment of total bone marrow irradiation (TMI) and total bone marrow and lymph nodal irradiation (TMLI) using Volumetric modulated ar...

    Authors: Tanweer Shahid, Sourav Mandal, Subhra Snigdha Biswal, Arundhati De, Mukti Mukherjee, Sandipan Roy Chowdhury, Anupam Chakrapani, Kirubha George, Jibak Bhattacharya, Prosenjit Soren, Tanmoy Ghosh, Biplab Sarkar and Luca Cozzi
    Citation: Radiation Oncology 2022 17:145
  19. As one of the most common chromosomal causes, chromosome translocation leads to T-cell acute lymphoblastic leukemia (T-ALL). Ku70 is one of the key factors of error-prone DNA repair and it may end in transloca...

    Authors: Zhenbo Cheng, Yupeng Wang, Lihuang Guo, Jiancheng Li, Wei Zhang, Conghui Zhang, Yangxu Liu, Yue Huang and Keqian Xu
    Citation: Radiation Oncology 2022 17:144
  20. A previous score predicted death ≤ 2 months following radiotherapy for MSCC. For patients with a high probability of early death, best supportive care was recommended. However, some of these patients may benef...

    Authors: Dirk Rades, Barbara Segedin, Steven E. Schild, Darejan Lomidze, Theo Veninga and Jon Cacicedo
    Citation: Radiation Oncology 2022 17:143
  21. Systemic inflammation is predictive of the overall survival in cancer patients and is related to the density of immune cells in the tumor microenvironment of cancer, which in turn correlates with 18F -fluorodeoxy...

    Authors: Beat Bojaxhiu, Dubravko Sinovcic, Olgun Elicin, Arnoud J. Templeton, Mohamed Shelan, Jan Wartenberg, Ian Alberts, Axel Rominger, Daniel M. Aebersold and Kathrin Zaugg
    Citation: Radiation Oncology 2022 17:141
  22. Brainstem metastases (BSM) are associated with a poor prognosis and their management represents a therapeutic challenge. BSM are often inoperable and, in absence of randomized trials, the optimal radiation tre...

    Authors: Luca Nicosia, Piera Navarria, Valentina Pinzi, Martina Giraffa, Ivana Russo, Paolo Tini, Niccolò Giaj-Levra, Filippo Alongi and Giuseppe Minniti
    Citation: Radiation Oncology 2022 17:140
  23. Standard treatment of soft tissue sarcoma (STS) of the extremities includes limb-sparing surgery combined with pre- or postoperative radiotherapy (RT). The role of perioperative chemotherapy (CTX) remains unce...

    Authors: Marta Kobus, Siyer Roohani, Felix Ehret, Anne Flörcken, Jana Käthe Striefler, Franziska Brandes, Sven Märdian, Daniel Rau, Silvan Wittenberg, Robert Öllinger and David Kaul
    Citation: Radiation Oncology 2022 17:139
  24. Using real-world evidence, this study aimed to identify elderly nasopharyngeal carcinoma (NPC) patients who would benefit from chemotherapy.

    Authors: Yan-Ling Wu, Kai-Bin Yang, Ying Huang, Jing-Rong Shi, Qing-Shui He, Lei Chen, Wen-Fei Li, Xiao-Dan Huang, Li Lin, Yu-Pei Chen, Yan-Ping Mao, Ling-Long Tang and Jun Ma
    Citation: Radiation Oncology 2022 17:138
  25. Langerhans cell histiocytosis (LCH) is a rare haematological neoplasm characterized by the accumulation of CD1a+, CD207/Langerin+ histiocytes within inflammatory lesions. LCH can involve any organ, but osteolytic...

    Authors: Wilmar Ghuijs, Paul G. Kemps, Marta E. Capala, Robert M. Verdijk, Astrid G. S. van Halteren, Robert J. P. van der Wal and Jan A. M. van Laar
    Citation: Radiation Oncology 2022 17:137
  26. In clinical practice, the organs at risk (OARs) should be carefully determined when performing pancreatic stereotactic body radiotherapy (SBRT). We conducted a simulation study to examine the effect of the sto...

    Authors: Osamu Tanaka, Takuya Taniguchi, Kousei Adachi, Shuto Nakaya, Takuji Kiryu, Akira Ukai, Chiyoko Makita and Masayuki Matsuo
    Citation: Radiation Oncology 2022 17:136
  27. To retrospectively analyze the efficacy and safety of concurrent chemoradiotherapy (CCRT) plus recombinant human endostatin (Endostar, CCRT + E) versus CCRT alone in locally advanced nasopharyngeal carcinoma (...

    Authors: Yuanxiu Yin, Ziyan Zhou, Zhiru Li, Mingjun Shen, Yating Qin, Chaolin Yang, Rensheng Wang and Min Kang
    Citation: Radiation Oncology 2022 17:135
  28. Definitive chemoradiotherapy has established the standard non-surgical treatment for locally advanced esophageal cancer. The standard dose of 50–50.4 Gy has been established decades ago and been confirmed in m...

    Authors: Hongcheng Zhu, Qiufang Liu, Hao Xu, Miao Mo, Zezhou Wang, Kui Lu, Jialiang Zhou, Junqiang Chen, Xiangpeng Zheng, Jinjun Ye, Xiaolin Ge, Honglei Luo, Qi Liu, Jiaying Deng, Dashan Ai, Shengnan Hao…
    Citation: Radiation Oncology 2022 17:134
  29. JCOG1015A1 is an ancillary research study to determine the organ-specific dose constraints in head and neck carcinoma treated with intensity-modulated radiation therapy (IMRT) using data from JCOG1015.

    Authors: Masahiro Inada, Yasumasa Nishimura, Satoshi Ishikura, Kazuki Ishikawa, Naoya Murakami, Takeshi Kodaira, Yoshinori Ito, Kazuhiko Tsuchiya, Yuji Murakami, Junichi Saito, Tetsuo Akimoto, Kensei Nakata, Michio Yoshimura, Teruki Teshima, Takashi Toshiyasu, Yosuke Ota…
    Citation: Radiation Oncology 2022 17:133
  30. To evaluate the clinical outcomes of hypofractionated stereotactic radiotherapy (HFSRT) combined with whole brain radiotherapy (WBRT) in patients with brain metastases (BMs).

    Authors: Xue-Yi Xie, Hong-Hua Peng, Xi Zhang, Yu-Liang Pan, Zhen Zhang and Pei-Guo Cao
    Citation: Radiation Oncology 2022 17:132
  31. Dose-escalation to above 80 Gy during external beam radiotherapy for localised prostate cancer leads to improved oncological outcomes but also substantially increased rectal toxicity. The aim of this study was...

    Authors: Andrew W. See, Patrick Bowden, Geoffrey Wells, Sree Appu, Nathan Lawrentschuk, Peter Liodakis, Chloe Pandeli, Yolanda Aarons, Lloyd M. L. Smyth and Dean P. McKenzie
    Citation: Radiation Oncology 2022 17:131
  32. Increased head and neck cancer (HNC) survival requires attention to long-term treatment sequelae. Irradiated HNC survivors have a higher ischemic stroke risk. However, the pathophysiology of radiation-induced ...

    Authors: Judith T. Pruijssen, Joyce Wilbers, Frederick J. A. Meijer, Sjoert A. H. Pegge, Jacqueline J. Loonen, Chris L. de Korte, Johannes H. A. M. Kaanders and Hendrik H. G. Hansen
    Citation: Radiation Oncology 2022 17:130
  33. We describe and evaluate a deep network algorithm which automatically contours organs at risk in the thorax and pelvis on computed tomography (CT) images for radiation treatment planning.

    Authors: Sebastian Marschner, Manasi Datar, Aurélie Gaasch, Zhoubing Xu, Sasa Grbic, Guillaume Chabin, Bernhard Geiger, Julian Rosenman, Stefanie Corradini, Maximilian Niyazi, Tobias Heimann, Christian Möhler, Fernando Vega, Claus Belka and Christian Thieke
    Citation: Radiation Oncology 2022 17:129

    The Correction to this article has been published in Radiation Oncology 2022 17:149

  34. This retrospective study was performed to evaluate the efficacy and toxicity of high-dose stereotactic body radiotherapy (SBRT) using a CyberKnife® for patients with stage I peripheral non-small cell lung canc...

    Authors: Yasuhiro Ryuno, Takanori Abe, Misaki Iino, Satoshi Saito, Tomomi Aoshika, Tomohiro Oota, Mitsunobu Igari, Ryuta Hirai, Yu Kumazaki, Kyoichi Kaira, Hiroshi Kagamu, Hironori Ishida, Shin-ei Noda and Shingo Kato
    Citation: Radiation Oncology 2022 17:128
  35. Tumor-infiltrating lymphocytes (TILs), investigated using routine hematoxylin and eosin (H&E)-stained section slides (H&E-sTILs), provide a robust prognostic biomarker in various types of solid cancer. The pur...

    Authors: Guangrun Zhou, Jifang Zheng, Zhiwei Chen, Dan Hu, Suyu Li, Wu Zhuang, Zhiyong He, Gen Lin, Biao Wu, Wei Zhang, Weimin Fang, Fei Zheng, Jiezhong Wang, Gang Chen and Mingqiu Chen
    Citation: Radiation Oncology 2022 17:127
  36. To examine long-term-survival of cT4 cN0/1 cM0 non-small-cell lung carcinoma (NSCLC) patients undergoing definitive radiochemotherapy (ccRTx/CTx) in comparison to the trimodality treatment, neoadjuvant radiochemo...

    Authors: Nika Guberina, Christoph Pöttgen, Martin Schuler, Maja Guberina, Georgios Stamatis, Till Plönes, Martin Metzenmacher, Dirk Theegarten, Thomas Gauler, Kaid Darwiche, Clemens Aigner, Wilfried E. E. Eberhardt and Martin Stuschke
    Citation: Radiation Oncology 2022 17:126
  37. tumor recurrence after NSCLC surgical resection is the most common cause of treatment failure that sharply reduces the patient’s life expectancy. The optimal treatment strategy for loco-regional recurrences de...

    Authors: Paolo Borghetti, Jessica Imbrescia, Giulia Volpi, Vieri Scotti, Michele Aquilano, Alessio Bruni, Davide Franceschini, Stefano Ursino, Patrizia Ciammella, Gaia Piperno, Maria Taraborrelli and Stefano Maria Magrini
    Citation: Radiation Oncology 2022 17:124
  38. The study evaluated the differences in leaf positioning deviations by the log files of three advanced accelerators with two delivery techniques, and established specific assessment parameters of leaf positioni...

    Authors: Xiutong Lin, Tao Sun, Xiao Liu, Guifang Zhang and Yong Yin
    Citation: Radiation Oncology 2022 17:123
  39. Dynamic trajectory radiotherapy (DTRT) extends volumetric modulated arc therapy (VMAT) with dynamic table and collimator rotation during beam-on. The aim of the study is to establish DTRT path-finding strategi...

    Authors: Jenny Bertholet, Paul-Henry Mackeprang, Silvan Mueller, Gian Guyer, Hannes A. Loebner, Yanick Wyss, Daniel Frei, Werner Volken, Olgun Elicin, Daniel M. Aebersold, Michael K. Fix and Peter Manser
    Citation: Radiation Oncology 2022 17:122
  40. Carbon ion radiotherapy (CIRT) yields biophysical advantages compared to photons but randomized studies for the reirradiation setting are pending. The aim of the current project was to evaluate potential clini...

    Authors: Thomas Held, Thomas Tessonnier, Henrik Franke, Sebastian Regnery, Lukas Bauer, Katharina Weusthof, Semi Harrabi, Klaus Herfarth, Andrea Mairani, Jürgen Debus and Sebastian Adeberg
    Citation: Radiation Oncology 2022 17:121
  41. In radiation treatment of locally advanced non-small cell lung cancer (LA-NSCLC), ‘margins’ from internal target volumes to planning target volumes in the range of 12 to 23 mm are reported, and avoiding exposu...

    Authors: Karl Wurstbauer, Margit Kazil, Marco Meinschad, Raoul Pinter, Catharina De Vries, Patrick Clemens, Christof Kreuter, Tamara Hernler, Wolfgang Hitzl, Peter Cerkl, Thomas Künzler and Alexander De Vries
    Citation: Radiation Oncology 2022 17:120
  42. Pure mucinous breast cancer is a rare subtype of invasive breast cancer with favorable prognosis, in which the effect of postoperative radiotherapy remains unclear. We aimed to investigate the prognostic value...

    Authors: Qiuping Mo, Yongzhen Wang, JinLan Shan and Xiaochen Wang
    Citation: Radiation Oncology 2022 17:119
  43. Gallbladder cancer (GBC) is an uncommon malignancy with high recurrent rate and poor prognosis. This study investigates the recurrent patterns of postoperative GBC, with the aim to guide the adjuvant treatment...

    Authors: Zhijun Yuan, Yongjie Shui, Lihong Liu, Yinglu Guo and Qichun Wei
    Citation: Radiation Oncology 2022 17:118
  44. Emerging evidence shows that immune checkpoint inhibitors lead to durable responses in a variety of cancers, including nasopharyngeal carcinoma (NPC), however, combination approaches (i.e., stereotactic body r...

    Authors: Jing Lin, Qiaojuan Guo, Zengqing Guo, Tianzhu Lu, Gang Chen, Shaojun Lin, Mei Chen, Chuanben Chen, Jianping Lu, Jingfeng Zong, Lina Tang, Yu Chen and Jianji Pan
    Citation: Radiation Oncology 2022 17:117
  45. Automated treatment planning systems are available for linear accelerator (linac)-based single-isocenter multi-target (SIMT) stereotactic radiosurgery (SRS) of brain metastases. In this study, we compared plan...

    Authors: Giorgio Hamid Raza, Luca Capone, Paolo Tini, Martina Giraffa, Piercarlo Gentile and Giuseppe Minniti
    Citation: Radiation Oncology 2022 17:116
  46. To report our experience with image guided pencil beam proton beam therapy (PBT) for craniospinal irradiation (CSI).

    Authors: Utpal Gaikwad, M. P. Noufal, Jacinthlyn Sylvia, Ashok K. Reddy, Pankaj Kumar Panda, Srinivas Chilukuri, Dayananda Sharma and Rakesh Jalali
    Citation: Radiation Oncology 2022 17:115

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions